Roydeva, P.G.; Beckmann, A.-M.; Stirnberg, M.; Cesar, J.; Kikelj, D.; Ilaš, J.; Gütschow, M.
3,1-Benzothiazines, 1,4-Benzodioxines and 1,4-Benzoxazines as Inhibitors of Matriptase-2: Outcome of a Focused Screening Approach. Pharmaceuticals 2016, 9, 2.
https://doi.org/10.3390/ph9010002
AMA Style
Roydeva PG, Beckmann A-M, Stirnberg M, Cesar J, Kikelj D, Ilaš J, Gütschow M.
3,1-Benzothiazines, 1,4-Benzodioxines and 1,4-Benzoxazines as Inhibitors of Matriptase-2: Outcome of a Focused Screening Approach. Pharmaceuticals. 2016; 9(1):2.
https://doi.org/10.3390/ph9010002
Chicago/Turabian Style
Roydeva, Polya G., Anna-Madeleine Beckmann, Marit Stirnberg, Jožko Cesar, Danijel Kikelj, Janez Ilaš, and Michael Gütschow.
2016. "3,1-Benzothiazines, 1,4-Benzodioxines and 1,4-Benzoxazines as Inhibitors of Matriptase-2: Outcome of a Focused Screening Approach" Pharmaceuticals 9, no. 1: 2.
https://doi.org/10.3390/ph9010002
APA Style
Roydeva, P. G., Beckmann, A.-M., Stirnberg, M., Cesar, J., Kikelj, D., Ilaš, J., & Gütschow, M.
(2016). 3,1-Benzothiazines, 1,4-Benzodioxines and 1,4-Benzoxazines as Inhibitors of Matriptase-2: Outcome of a Focused Screening Approach. Pharmaceuticals, 9(1), 2.
https://doi.org/10.3390/ph9010002